Skip to main content
Top
Published in: Journal of Neurology 9/2009

Open Access 01-09-2009 | Review

Prevalence and definition of drooling in Parkinson’s disease: a systematic review

Authors: J. G. Kalf, B. J. M. de Swart, G. F. Borm, B. R. Bloem, M. Munneke

Published in: Journal of Neurology | Issue 9/2009

Login to get access

Abstract

Drooling (saliva loss) is a frequently reported symptom in patients with Parkinson’s disease (PD), but an accurate estimate of the prevalence of drooling is lacking. The aim of this study was to systematically review the prevalence of drooling in published research papers. A systematic PubMed and CINAHL search was done, including studies published until January 2009. Eight studies were found, presenting prevalence rates of drooling based on responses of PD patients to questionnaires. The statistical heterogeneity was highly significant (P < 0.0001), with prevalence rates ranging from 32 to 74%. The pooled prevalence estimate with random effect analysis was of 56% (95% CI 44–67) for PD patients and 14% (95% CI 3–25) for healthy controls; the pooled relative risk (RR) with random effect analysis was 5.5 (95% CI 2.1–14.4). All studies reported data of community dwelling idiopathic PD patients, with a mean age around 65 years and mild PD in 50–60% of the cases. Heterogeneity was mainly caused by differences in definition or frequency of drooling. The highest prevalence rates included nocturnal drooling where others noted only diurnal drooling. Analysis of the data of two studies showed that drooling is reported frequently by 22–26% of the patients. Prevalence rates were lower in milder PD patients. The summarized findings demonstrate that drooling can be present in half of all PD patients. In about a quarter of PD patients, drooling appears to be a frequently occurring problem. We recommend to report drooling in future studies with more detailed consideration of severity, frequency and nocturnal versus diurnal complaints.
Literature
2.
go back to reference de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240–1244PubMed de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240–1244PubMed
3.
go back to reference Eadie MJ, Tyrer JH (1965) Alimentary disorder in Parkinsonism. Australas Ann Med 14:13–22PubMed Eadie MJ, Tyrer JH (1965) Alimentary disorder in Parkinsonism. Australas Ann Med 14:13–22PubMed
5.
go back to reference Egger M, Smith GD, Altman DG (2001) Sytematic reviews in health care: meta-analysis in context. Blackwell BMJ Books, LondonCrossRef Egger M, Smith GD, Altman DG (2001) Sytematic reviews in health care: meta-analysis in context. Blackwell BMJ Books, LondonCrossRef
7.
8.
go back to reference Hartelius L, Svensson P (1994) Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: a survey. Folia Phoniatr Logop 46:9–17PubMedCrossRef Hartelius L, Svensson P (1994) Speech and swallowing symptoms associated with Parkinson’s disease and multiple sclerosis: a survey. Folia Phoniatr Logop 46:9–17PubMedCrossRef
9.
go back to reference Hyson HC, Johnson A, Wiebe S, Jog MS (2001) Survey of sialorrhea in parkinsonian patients in southwestern Ontario. Can J Neurol Sci 28:S46–S47 Hyson HC, Johnson A, Wiebe S, Jog MS (2001) Survey of sialorrhea in parkinsonian patients in southwestern Ontario. Can J Neurol Sci 28:S46–S47
10.
go back to reference Kalf JG, de Swart BJM, Zwarts MJ, Munneke M, Bloem BR (2008) Frequency of oral motor impairments in Parkinson’s disease and implications for referral to speech therapists. Mov Disord 23:S328 Kalf JG, de Swart BJM, Zwarts MJ, Munneke M, Bloem BR (2008) Frequency of oral motor impairments in Parkinson’s disease and implications for referral to speech therapists. Mov Disord 23:S328
12.
go back to reference Kurlan R (2005) “Levodopa phobia”: a new iatrogenic cause of disability in Parkinson disease. Neurology 64:923–924PubMed Kurlan R (2005) “Levodopa phobia”: a new iatrogenic cause of disability in Parkinson disease. Neurology 64:923–924PubMed
13.
go back to reference Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, Macmahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629. doi:10.1002/mds.21586 PubMedCrossRef Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, Macmahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629. doi:10.​1002/​mds.​21586 PubMedCrossRef
18.
go back to reference Streiner DL, Norman GR (2003) Health measurement scales: a practical guide to their development and use. Oxford University Press, Oxford Streiner DL, Norman GR (2003) Health measurement scales: a practical guide to their development and use. Oxford University Press, Oxford
Metadata
Title
Prevalence and definition of drooling in Parkinson’s disease: a systematic review
Authors
J. G. Kalf
B. J. M. de Swart
G. F. Borm
B. R. Bloem
M. Munneke
Publication date
01-09-2009
Publisher
D. Steinkopff-Verlag
Published in
Journal of Neurology / Issue 9/2009
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5098-2

Other articles of this Issue 9/2009

Journal of Neurology 9/2009 Go to the issue